Aristeia Capital’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,303,646
| Closed | -$1.63K | – | 482 |
|
|
2024
Q2 | $1.63K | Sell |
1,303,646
-29,800
| -2% | -$37 | ﹤0.01% | 332 |
|
|
2024
Q1 | $183K | Sell |
1,333,446
-159,746
| -11% | -$22K | ﹤0.01% | 172 |
|
|
2023
Q4 | $158K | Sell |
1,493,192
-100
| -0% | -$11 | ﹤0.01% | 83 |
|
|
2023
Q3 | $161K | Sell |
1,493,292
-4,403
| -0.3% | -$476 | ﹤0.01% | 89 |
|
|
2023
Q2 | $260K | Sell |
1,497,695
-42,602
| -3% | -$7.39K | 0.01% | 123 |
|
|
2023
Q1 | $153K | Hold |
1,540,297
| – | – | ﹤0.01% | 222 |
|
|
2022
Q4 | $174K | Sell |
1,540,297
-17,177
| -1% | -$1.94K | ﹤0.01% | 328 |
|
|
2022
Q3 | $264K | Sell |
1,557,474
-56,613
| -4% | -$9.6K | ﹤0.01% | 424 |
|
|
2022
Q2 | $379K | Hold |
1,614,087
| – | – | 0.01% | 395 |
|
|
2022
Q1 | $634K | Sell |
1,614,087
-117,859
| -7% | -$46.3K | 0.01% | 389 |
|
|
2021
Q4 | $1.54M | Sell |
1,731,946
-18,054
| -1% | -$16.1K | 0.03% | 385 |
|
|
2021
Q3 | $2.84M | Buy |
1,750,000
+1,466,871
| +518% | +$2.38M | 0.05% | 299 |
|
|
2021
Q2 | $283K | Buy |
+283,129
| New | +$283K | 0.01% | 424 |
|